PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 31 filers reported holding PDL BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $916,000 | -10.4% | 16,672,000 | -2.0% | 0.14% | -22.9% |
| Q3 2015 | $1,022,000 | -5.5% | 17,006,000 | +1390.4% | 0.18% | -23.2% |
| Q2 2015 | $1,081,000 | -97.2% | 1,141,000 | -4.3% | 0.23% | -95.8% |
| Q1 2015 | $39,074,000 | -6.1% | 1,192,606 | -0.1% | 5.40% | +5.5% |
| Q4 2014 | $41,614,000 | -6.0% | 1,193,517 | -97.4% | 5.12% | +4.3% |
| Q3 2014 | $44,278,000 | -19.3% | 45,357,000 | -6.4% | 4.91% | -22.9% |
| Q2 2014 | $54,882,000 | +9.7% | 48,476,000 | +0.9% | 6.36% | +0.5% |
| Q1 2014 | $50,049,000 | – | 48,064,000 | – | 6.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 19,703,000 | $19,738,000 | 2.83% |
| ASCEND CAPITAL, LLC | 43,840,000 | $43,727,000 | 1.65% |
| ZAZOVE ASSOCIATES LLC | 2,080,000 | $2,085,000 | 0.11% |
| Verition Fund Management LLC | 1,000,000 | $1,004,000 | 0.08% |
| OAKTREE CAPITAL MANAGEMENT LP | 4,940,000 | $4,940,000 | 0.07% |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 3,420,000 | $3,424,000 | 0.05% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 37,800,000 | $37,702,476,000 | 0.03% |
| Sterneck Capital Management, LLC | 18,000 | $18,000 | 0.01% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 235,000 | $212,000 | 0.00% |
| INVESTMENT CENTERS OF AMERICA INC | 50,000 | $50,000 | 0.00% |